2m 2m 2m 2m 2m 2m 2m
ALCON N (ALC)
NYSE
$66.14+$0.96 (+1.47%)
Price as of Jun 23, 2026 4:10 PM EDT- $32.6BMarket Cap
- -23.26%1-Year Change
- Medical Instruments & SuppliesIndustry
ALCON N (ALC)
$66.14+$0.96 (+1.47%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 10.4B +4.94% | 9.9B +4.82% | 9.5B +8.47% | 8.7B +5.14% | |
Cost of Revenue | 4.6B +6.10% | 4.3B +4.52% | 4.1B +5.91% | 3.9B +9.31% | |
Gross Profit | 5.7B +4.23% | 5.5B +5.05% | 5.2B +10.51% | 4.7B +2.06% | |
Sales and Marketing Expense | 3.4B +6.12% | 3.3B +1.28% | 3.2B +4.60% | 3.1B -0.26% | |
Research and Development Expense | -990.0M +13.01% | -876.0M +5.80% | -828.0M +17.95% | -702.0M -16.63% | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 3.4B +6.12% | 3.3B +1.28% | 3.2B +4.60% | 3.1B -0.26% | |
Operating Profit | 1.4B -3.75% | 1.4B +36.00% | 1.0B +54.61% | 672.0M +15.86% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -204.0M +6.25% | -192.0M +1.59% | -189.0M +41.04% | -134.0M +11.67% | |
Interest Income and Expense and Net | -204.0M +6.25% | -192.0M +1.59% | -189.0M +41.04% | -134.0M +11.67% | |
Total Nonoperating Income and Expense | 204.0M +6.25% | 192.0M +1.59% | 189.0M +41.04% | 134.0M +11.67% | |
Income before Taxes | 980.0M -3.73% | 1.0B +4.52% | 974.0M +190.75% | 335.0M -10.90% | |
Income Taxes | 180.0M -24.37% | 238.0M +267.61% | -142.0M -210.94% | 128.0M +204.76% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 980.0M -3.73% | 1.0B +4.52% | 974.0M +190.75% | 335.0M -10.90% | |
Net Income from Continuing Operations Applicable to Common | 980.0M -3.73% | 1.0B +4.52% | 974.0M +190.75% | 335.0M -10.90% | |
Basic EPS and Net Income | 1.99 -3.40% | 2.06 +4.04% | 1.98 +191.18% | 0.68 -11.69% | |
Diluted EPS and Net Income | 1.98 -3.41% | 2.05 +4.59% | 1.96 +188.24% | 0.68 -10.53% | |
Basic Weighted Average Shares | 493.2M -0.24% | 494.4M +0.28% | 493.0M +0.33% | 491.4M +0.29% | |
Diluted Weighted Average Shares | 493.2M -0.24% | 494.4M +0.28% | 493.0M +0.33% | 491.4M +0.29% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.5B -8.89% | 1.7B +53.20% | 1.1B +11.63% | 980.0M -37.78% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Cash and Cash Equivalents and Short-Term Investments | 1.5B -8.89% | 1.7B +53.20% | 1.1B +11.63% | 980.0M -37.90% | |
Total Current Assets | 6.4B +2.22% | 6.3B +11.72% | 5.6B +8.74% | 5.2B -3.58% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 4.8B +8.77% | 4.4B +0.46% | 4.4B +8.55% | 4.0B +8.46% | |
Total Long-Term Assets | 25.1B +4.44% | 24.0B +0.30% | 24.0B -0.20% | 24.0B +6.20% | |
Total Assets | 31.6B +3.98% | 30.3B +2.48% | 29.6B +1.39% | 29.2B +4.32% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 82.0M N/A | N/A N/A | |
Total Current Liabilities | 3.0B +33.85% | 2.3B -8.15% | 2.5B -10.86% | 2.8B +12.54% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 6.5B -0.69% | 6.5B +0.09% | 6.5B -3.56% | 6.8B +7.64% | |
Total Liabilities | 9.5B +8.26% | 8.8B -2.18% | 9.0B -5.69% | 9.5B +9.02% | |
Retained Earnings | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Stockholders Equity | 22.0B +2.24% | 21.6B +4.50% | 20.6B +4.81% | 19.7B +2.19% | |
Total Shares Outstanding | 487.4M -1.46% | 494.6M +0.28% | 493.2M +0.28% | 491.8M +0.35% | |
Cash Flow | |||||
Cash from Operating Activities | 2.3B +9.34% | 2.1B +49.64% | 1.4B +14.05% | 1.2B -9.52% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -1.3B +15.17% | -1.2B +6.67% | -1.1B -41.34% | -1.9B +55.68% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -1.1B +247.52% | -322.0M +52.61% | -211.0M +2,537.50% | -8.0M -93.50% | |
Financials Ratio | |||||
Gross Margin | 55.85% -0.85% | 56.33% +0.23% | 56.20% +1.92% | 55.15% -3.01% | |
Operating Margin | 13.08% -8.29% | 14.26% +29.74% | 10.99% +42.54% | 7.71% +10.20% | |
Return on Assets | 3.17% -6.75% | 3.40% +2.53% | 3.31% +182.75% | 1.17% -13.40% | |
Return on Equity | 4.50% -6.85% | 4.83% -0.13% | 4.83% +180.88% | 1.72% -12.86% | |
Revenue Growth | 4.94% +2.51% | 4.82% -43.03% | 8.47% +64.77% | 5.14% -75.92% | |
Current Ratio | 2.12 -23.63% | 2.77 +21.63% | 2.28 +21.99% | 1.87 -14.33% | |
Cash Ratio | 0.50 -31.93% | 0.74 +66.79% | 0.44 +25.21% | 0.35 -44.70% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow